Group structure
7 companies in 4 countries
Loading your pageโฆ
Loading your pageโฆ
7 companies in 4 countries
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine of every company in the group, current ones first.
9 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| Abakavir/lamivudin Remedica 600 mg/300 mg filmom obloลพene tablete*filmom obloลพena tableta | Abacavir, Lamivudine | Croatia | Not marketed | 2022 |
| Emtricitabin/tenofovirdizoproksil Remedica 200 mg/245 mg filmom obloลพene tablete*filmom obloลพena tableta | Emtricitabine, Tenofovir disoproxil | Croatia | Not marketed | 2022 |
| Lenvatinib Remedica 10 mg, harde capsulesCapsule, hard | Lenvatinib | Netherlands | Authorised | 2025 |
| Lenvatinib Remedica 10 mg tvrde kapsuleKapsula, tvrda | Lenvatinib | Croatia | Not marketed | 2025 |
| Lenvatinib Remedica 4 mg, harde capsulesCapsule, hard | Lenvatinib | Netherlands | Authorised | 2025 |
| Lenvatinib Remedica 4 mg tvrde kapsuleKapsula, tvrda | Lenvatinib | Croatia | Not marketed | 2025 |
| Fylibix | Dasatinib | Saudi Arabia | Authorised | |
| KORANDIL | Enalapril | Saudi Arabia | Authorised | |
| Tyrox | Erlotinib | Saudi Arabia | Authorised |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Croatia | 4 | 4 | 0 | CompaniesAll medicines |
| Saudi Arabia | 3 | 3 | 0 | CompaniesAll medicines |
| Netherlands | 2 | 2 | 0 | CompaniesAll medicines |
The ATC groups most of its medicines belong to, largest first.
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Companies are grouped by Prognia from the names regulators publish; not an official corporate structure.
Anvisa, official medicine/API manufacturer factual export, HTTP source version Fri, 09 Oct 2026 08:21:54 GMT, acquired 2026-10-09; exact unmodified native identifiers and fields preserved.
Licence: Brazil federal factual open-data reuse; Decreto 8777/2016 consolidated article 4 and third-party exceptions
HALMED, Baza lijekova, source export 08.10.2026., acquired 2026-10-08; factual structured adaptation; Otvorena dozvola RH, NN 67/2017.
Licence: Otvorena dozvola RH
College ter Beoordeling van Geneesmiddelen, Geneesmiddeleninformatiebank metadata, source update 07-10-2026; downloaded 08-10-2026; factual adaptation.
Licence: Conditional noncreative administrative factual metadata; no dataset-wide CC0 claim
Oficiul Naศional al Registrului Comerศului; exact original source URLs, snapshot2026-09-02 where applicable, retrieval date, original record locators; https://creativecommons.org/licenses/by/4.0/
Licence: Creative Commons Attribution
ALIMS, Registar humanih lekova, source 08.10.2026 02:00, downloaded 2026-10-08, https://data.gov.rs/sr/datasets/lekovi-za-upotrebu-u-khumanoj-meditsini/; structured factual adaptation; Serbian Open Data Licence.
Licence: Serbian Open Data Licence (sodl)
Saudi Food and Drug Authority (SFDA), foreign human medicine open-data listing, source scope 2023, retrieved 11 October 2026 UTC; exact original file and response modification date retained.
Licence: Exact SFDA open-data section explicitly offers freely usable named human medicine workbooks; factual-data scope only
Contains information from HSA Listing of Registered Therapeutic Products accessed on 8 October 2026 from data.gov.sg, under Singapore Open Data Licence 1.0: https://data.gov.sg/open-data-licence
Licence: Singapore Open Data Licence
Report an error or request removalCorrections from the company itself are welcome.
Well-known pharmaceutical groups, each with all its companies.